BMG524411052
BMG524411052
Kestra Medical Technologies, Lt
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q3 '26 31.07.2026 | Q2 '26 30.04.2026 | Q1 '26 31.01.2026 | Q4 '25 31.10.2025 |
|---|---|---|---|---|---|
Market & Enterprise Value | |||||
Market Cap | 1.61B EUR | 1.35B EUR | 1.21B EUR | 1.44B EUR | 1.41B EUR |
Enterprise Value | 1.41B EUR | 1.36B EUR | 1.16B EUR | 1.19B EUR | 1.28B EUR |
Valuation Multiples | |||||
Trailing P/E | -- | -- | -- | -- | -- |
Forward P/E | -13.13x | -- | -- | -- | -- |
Price to Sales | 15.06x | 12.68x | 12.72x | 21.65x | 33.59x |
Price to Book | 7.19x | 6.09x | 4.66x | 5x | 8.59x |
EV/Revenue | 13.23x | 12.75x | 12.16x | 17.97x | 30.48x |
EV/EBITDA | -10.53x | -- | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- | -- |
FCF Yield | -4.48% | -9.11% | -9.68% | -6.16% | -4.29% |